Cite
Global Oncology Molecular Diagnostics to 2027: U.S. Accounts for Over 28.8% in 2020, While China is Forecast to Grow at a 14.9% CAGR
MLA
“Global Oncology Molecular Diagnostics to 2027: U.S. Accounts for Over 28.8% in 2020, While China Is Forecast to Grow at a 14.9% CAGR.” GlobeNewswire, 9 Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.637832172&authtype=sso&custid=ns315887.
APA
Global Oncology Molecular Diagnostics to 2027: U.S. Accounts for Over 28.8% in 2020, While China is Forecast to Grow at a 14.9% CAGR. (2020, October 9). GlobeNewswire.
Chicago
GlobeNewswire. 2020. “Global Oncology Molecular Diagnostics to 2027: U.S. Accounts for Over 28.8% in 2020, While China Is Forecast to Grow at a 14.9% CAGR,” October 9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.637832172&authtype=sso&custid=ns315887.